U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Integra Neurosciences PR, Inc. - 01/14/2015
  1. Warning Letters


Integra Neurosciences PR, Inc.

Integra Neurosciences PR, Inc.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

 Food and Drug Administration
466 Fernandez Juncos Avenue
San Juan, Puerto Rico, 00901
Telephone: 787-729-8500
FAX: 787-729-8826

January 14, 2015



Mr. Peter Arduini
President and CEO
Integra Life-Sciences Corporation
311 Enterprise Drive,
Plainsboro, N.J. 08536

Dear Mr. Arduini:

We have completed an evaluation of your firm's corrective actions in response to our Warning Letter 13-SJN-WL-03 dated February 13, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Should you have questions and/or comments regarding this matter, please feel free to contact me at the district office address provided in the letterhead. You may also contact Mrs. Margarita Santiago, Compliance Officer at telephone number (787) 729-8702 or at margarita.santiago@fda.hhs.gov.


Kind regards,


Edwin Ramos
Director of Compliance
San Juan District Office

Back to Top